Back
Politics

FDA Rules Allowing Telehealth Mifepristone Prescriptions Challenged in Court

View source

Legal Challenge to Mifepristone Access Nears Ruling

Mifepristone: Safety and Efficacy

Mifepristone, a medication utilized for over 25 years in the U.S. for first-trimester abortion and miscarriage management, is considered safe and effective by the medical community.

FDA Regulations Under Scrutiny

The Food and Drug Administration (FDA) has historically modified its regulations concerning access to this medication.

The latest legal challenge specifically targets the FDA's 2023 rule alteration, which authorized mifepristone to be prescribed via telemedicine and dispensed by mail.

Louisiana Lawsuit Filed

The state of Louisiana, along with a Louisiana patient, initiated the lawsuit.

A federal judge is anticipated to deliver a ruling on the matter in the near future.